| Record ID | marc_records_scriblio_net/part17.dat:75068159:1563 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part17.dat:75068159:1563?format=raw |
LEADER: 01563cam 2200301 a 4500
001 84062037 //r923
003 DLC
005 19920612084607.2
008 840919m19851986dcu b 001 0 eng
010 $a 84062037 //r923
020 $a0309034949 (pbk. : v. 1)
020 $a0309036798 (pbk. : v. 2)
040 $aDLC$cDLC$dDLC
043 $an-us---$ad------
050 00 $aRA638$b.N49 1985
082 00 $a614.4/7/0973$219
245 00 $aNew vaccine development :$bestablishing priorities /$cby the Committee on Issues and Priorities for New Vaccine Development, Division of Health Promotion and Disease Prevention, Institute of Medicine.
260 0 $aWashington, D.C. :$bNational Academy Press,$c1985-1986.
300 $a2 v. ;$c28 cm.
500 $aPrepared for the National Institute of Allergy and Infectious Diseases.
500 $aVol. 2 has statement of responsibility: by the Committee on Issues and Priorities for New Vaccine Development, Division of Health Promotion and Disease Prevention and Division of International Health, Institute of Medicine.
504 $aIncludes bibliographies and indexes.
505 0 $av. 1. Diseases of importance in the United States -- v. 2. Diseases of importance in developing countries.
650 0 $aVaccines$xResearch$xGovernment policy.
650 0 $aVaccination$zUnited States.
650 0 $aVaccination$zDeveloping countries.
710 20 $aInstitute of Medicine (U.S.).$bCommittee on Issues and Priorities for New Vaccine Development.
710 20 $aNational Institute of Allergy and Infectious Diseases (U.S.)